Literature DB >> 16385286

Immunoglobulin a modulates inflammatory responses in an in vitro model of pneumonia.

Lawrence N Diebel1, David M Liberati, Clement A Diglio, William J Brown.   

Abstract

BACKGROUND: Preservation of mucosal immunity has been shown to affect the risk and outcome of pneumonia in severely injured patients. Secretory immunoglobulin A (SIgA) is the principle humoral defense of mucosal surfaces in the body and has several antiinflammatory properties. Polymorphonuclear neutrophils (PMN) function to kill invading microorganisms, but their exaggerated inflammatory responses may cause tissue injury to the host. The purpose of this study was to compare the ability of different immunoglobulin (Ig) isotypes to modulate PMN cytotoxic potential cocultured with respiratory epithelial cells challenged with bacteria.
METHODS: Calu-3 cell monolayers were established on membranes (0.1-microm pore) in a two-chamber culture system. Escherichia coli (EC) incubated with either polyclonal SIgA or IgG was inoculated into the apical chamber and PMNs (10/mL) added to the basal chamber. PMN cytotoxic potential was indexed by % CD11b expression, superoxide anion (O2) production, and elastase release. Dextran flux was used to index Calu-3 monolayer permeability.
RESULTS: Addition of EC to PMN-Calu-3 cell coculture increased % CD11b expression, O2 production, and elastase release. IgG had no effect on PMN activation after EC challenge. SIgA abrogated PMN activation and the increase in Calu-3 cell monolayer permeability noted with EC or EC + IgG treatment groups.
CONCLUSION: PMN cytotoxic potential was decreased by the presence of SIgA but not IgG in an in vitro model to simulate pneumonia in vivo. SIgA may not only function to protect against microbial invasion of mucosal surfaces, but may also protect against tissue injury from an exaggerated inflammatory response.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16385286     DOI: 10.1097/01.ta.0000187797.38327.78

Source DB:  PubMed          Journal:  J Trauma        ISSN: 0022-5282


  5 in total

1.  Gut Lymphocyte Phenotype Changes After Parenteral Nutrition and Neuropeptide Administration.

Authors:  Mark A Jonker; Aaron F Heneghan; John H Fechner; Joseph F Pierre; Yoshifumi Sano; Jinggang Lan; Kenneth A Kudsk
Journal:  Ann Surg       Date:  2015-07       Impact factor: 12.969

2.  Small intestine mucosal immune system response to injury and the impact of parenteral nutrition.

Authors:  Mark A Jonker; Joshua L Hermsen; Yoshifumi Sano; Aaron F Heneghan; Jinggang Lan; Kenneth A Kudsk
Journal:  Surgery       Date:  2010-12-10       Impact factor: 3.982

3.  Intravenous immunoglobulin-based adjuvant therapy for severe COVID-19: a single-center retrospective cohort study.

Authors:  Xiao Hou; Li Tian; Lei Zhou; Xinhua Jia; Li Kong; Yitao Xue; Hao Hao; Xianqing Meng; Feihu Zhang; Xiaobin Dong
Journal:  Virol J       Date:  2021-05-21       Impact factor: 4.099

4.  Effect of regular intravenous immunoglobulin therapy on prognosis of severe pneumonia in patients with COVID-19.

Authors:  Yun Xie; Song Cao; Hui Dong; Qingyun Li; Erzhen Chen; Wenkai Zhang; Luyu Yang; Shouzhi Fu; Ruilan Wang
Journal:  J Infect       Date:  2020-04-10       Impact factor: 6.072

5.  Immunoglobulins concentration and B cell counts as severity markers in adult community-acquired pneumonia: Cross sectional study.

Authors:  Vivian Luchsinger; Luis Lizama; María Luisa Garmendia; Fabián Tempio; Mauricio Ruiz; Rolando Pizarro; Patricio Rossi; Lucía Huenchur; Cristian Moreno; Mercedes López; Sandra Ampuero; Carmen Larrañaga; Luis Fidel Avendaño
Journal:  Medicine (Baltimore)       Date:  2020-11-06       Impact factor: 1.817

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.